Ledger.Open graph →
SEC Form D · Amendment · filed November 9, 2023

Mediar Therapeutics, Inc

Offering
$85.0M
Sold
$60.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Michael Baran · Boston, MADirectorMeredith Fisher · Boston, MADirectorAndreas Jurgeit · Boston, MADirectorAnja Konig · Boston, MADirectorRahul Ballal · Boston, MAExec · DirectorMaina Bhaman · Boston, MADirectorPeter Parker · Wellesley, MADirectorPeter Parker · Danvers, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗